Dipyridamole reduced myocardial platelet and leukocyte deposition following ischemia and cardioplegia

Kevin H. Teoh, George T. Christakis, Richard D. Weisel, M. Mindy Madonik, Joan Ivanov, Ann Warbick-Cerone, Linda G. Johnston, Richard H. Cawthorn, John C. Mullen, Michael F X Glynn, Gregory J. Wilson, Tomas Salerno

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Urgent coronary revascularization for acute myocardial ischemia results in an increased mortality and morbidity. Deposition of activated platelets and leukocytes into the ischemic myocardium during reperfusion may augment perioperative ischemic injury. Dipyridamole reduces platelet activation and may reduce myocardial deposition and prevent ischemic injury during reperfusion. The effects of dipyridamole on myocardial platelet and leukocyte deposition were evaluated in a canine model of acute regional myocardial ischemia with reperfusion during cardioplegia on cardiopulmonary bypass. Eight dogs underwent left anterior descending (LAD) coronary artery ligation for 45 min followed by cardiopulmonary bypass and release of the ligature during 60 min of cold crystalloid cardioplegic arrest to stimulate urgent revascularization. Four dogs were randomized to receive an infusion of dipyridamole perioperatively (50 mg/hr) and 4 dogs served as controls. Autologous platelets were labeled with 111In, leukocytes with 99mTc, and erythrocytes with 51Cr. The labeled cells were infused immediately after cross-clamp release and myocardial biopsies were obtained at 10, 20, 30, and 60 min of reperfusion. Platelets were deposited in the myocardium during reperfusion and four times more platelets were found in the LAD region than the circumflex region. Leukocyte deposition was similar in the LAD and circumflex regions. Dipyridamole reduced both platelet and leukocyte deposition and the reduction was greater in the LAD than in the circumflex region. Myocardial platelet and leukocyte deposition was found after regional ischemia, cardioplegia, and cardiopulmonary bypass. Dipyridamole reduced myocardial platelet and leukocyte deposition and may reduce perioperative ischemic injury.

Original languageEnglish
Pages (from-to)642-652
Number of pages11
JournalJournal of Surgical Research
Volume42
Issue number6
DOIs
StatePublished - Jan 1 1987
Externally publishedYes

Fingerprint

Induced Heart Arrest
Dipyridamole
Leukocytes
Blood Platelets
Ischemia
Reperfusion
Cardiopulmonary Bypass
Dogs
Myocardial Ischemia
Ligation
Myocardium
Platelet Activation
Wounds and Injuries
Reperfusion Injury
Canidae
Coronary Vessels
Erythrocytes
Morbidity
Biopsy
Mortality

ASJC Scopus subject areas

  • Surgery

Cite this

Dipyridamole reduced myocardial platelet and leukocyte deposition following ischemia and cardioplegia. / Teoh, Kevin H.; Christakis, George T.; Weisel, Richard D.; Madonik, M. Mindy; Ivanov, Joan; Warbick-Cerone, Ann; Johnston, Linda G.; Cawthorn, Richard H.; Mullen, John C.; Glynn, Michael F X; Wilson, Gregory J.; Salerno, Tomas.

In: Journal of Surgical Research, Vol. 42, No. 6, 01.01.1987, p. 642-652.

Research output: Contribution to journalArticle

Teoh, KH, Christakis, GT, Weisel, RD, Madonik, MM, Ivanov, J, Warbick-Cerone, A, Johnston, LG, Cawthorn, RH, Mullen, JC, Glynn, MFX, Wilson, GJ & Salerno, T 1987, 'Dipyridamole reduced myocardial platelet and leukocyte deposition following ischemia and cardioplegia', Journal of Surgical Research, vol. 42, no. 6, pp. 642-652. https://doi.org/10.1016/0022-4804(87)90008-4
Teoh, Kevin H. ; Christakis, George T. ; Weisel, Richard D. ; Madonik, M. Mindy ; Ivanov, Joan ; Warbick-Cerone, Ann ; Johnston, Linda G. ; Cawthorn, Richard H. ; Mullen, John C. ; Glynn, Michael F X ; Wilson, Gregory J. ; Salerno, Tomas. / Dipyridamole reduced myocardial platelet and leukocyte deposition following ischemia and cardioplegia. In: Journal of Surgical Research. 1987 ; Vol. 42, No. 6. pp. 642-652.
@article{944af66796254e53900219f41af17b8a,
title = "Dipyridamole reduced myocardial platelet and leukocyte deposition following ischemia and cardioplegia",
abstract = "Urgent coronary revascularization for acute myocardial ischemia results in an increased mortality and morbidity. Deposition of activated platelets and leukocytes into the ischemic myocardium during reperfusion may augment perioperative ischemic injury. Dipyridamole reduces platelet activation and may reduce myocardial deposition and prevent ischemic injury during reperfusion. The effects of dipyridamole on myocardial platelet and leukocyte deposition were evaluated in a canine model of acute regional myocardial ischemia with reperfusion during cardioplegia on cardiopulmonary bypass. Eight dogs underwent left anterior descending (LAD) coronary artery ligation for 45 min followed by cardiopulmonary bypass and release of the ligature during 60 min of cold crystalloid cardioplegic arrest to stimulate urgent revascularization. Four dogs were randomized to receive an infusion of dipyridamole perioperatively (50 mg/hr) and 4 dogs served as controls. Autologous platelets were labeled with 111In, leukocytes with 99mTc, and erythrocytes with 51Cr. The labeled cells were infused immediately after cross-clamp release and myocardial biopsies were obtained at 10, 20, 30, and 60 min of reperfusion. Platelets were deposited in the myocardium during reperfusion and four times more platelets were found in the LAD region than the circumflex region. Leukocyte deposition was similar in the LAD and circumflex regions. Dipyridamole reduced both platelet and leukocyte deposition and the reduction was greater in the LAD than in the circumflex region. Myocardial platelet and leukocyte deposition was found after regional ischemia, cardioplegia, and cardiopulmonary bypass. Dipyridamole reduced myocardial platelet and leukocyte deposition and may reduce perioperative ischemic injury.",
author = "Teoh, {Kevin H.} and Christakis, {George T.} and Weisel, {Richard D.} and Madonik, {M. Mindy} and Joan Ivanov and Ann Warbick-Cerone and Johnston, {Linda G.} and Cawthorn, {Richard H.} and Mullen, {John C.} and Glynn, {Michael F X} and Wilson, {Gregory J.} and Tomas Salerno",
year = "1987",
month = "1",
day = "1",
doi = "10.1016/0022-4804(87)90008-4",
language = "English",
volume = "42",
pages = "642--652",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "6",

}

TY - JOUR

T1 - Dipyridamole reduced myocardial platelet and leukocyte deposition following ischemia and cardioplegia

AU - Teoh, Kevin H.

AU - Christakis, George T.

AU - Weisel, Richard D.

AU - Madonik, M. Mindy

AU - Ivanov, Joan

AU - Warbick-Cerone, Ann

AU - Johnston, Linda G.

AU - Cawthorn, Richard H.

AU - Mullen, John C.

AU - Glynn, Michael F X

AU - Wilson, Gregory J.

AU - Salerno, Tomas

PY - 1987/1/1

Y1 - 1987/1/1

N2 - Urgent coronary revascularization for acute myocardial ischemia results in an increased mortality and morbidity. Deposition of activated platelets and leukocytes into the ischemic myocardium during reperfusion may augment perioperative ischemic injury. Dipyridamole reduces platelet activation and may reduce myocardial deposition and prevent ischemic injury during reperfusion. The effects of dipyridamole on myocardial platelet and leukocyte deposition were evaluated in a canine model of acute regional myocardial ischemia with reperfusion during cardioplegia on cardiopulmonary bypass. Eight dogs underwent left anterior descending (LAD) coronary artery ligation for 45 min followed by cardiopulmonary bypass and release of the ligature during 60 min of cold crystalloid cardioplegic arrest to stimulate urgent revascularization. Four dogs were randomized to receive an infusion of dipyridamole perioperatively (50 mg/hr) and 4 dogs served as controls. Autologous platelets were labeled with 111In, leukocytes with 99mTc, and erythrocytes with 51Cr. The labeled cells were infused immediately after cross-clamp release and myocardial biopsies were obtained at 10, 20, 30, and 60 min of reperfusion. Platelets were deposited in the myocardium during reperfusion and four times more platelets were found in the LAD region than the circumflex region. Leukocyte deposition was similar in the LAD and circumflex regions. Dipyridamole reduced both platelet and leukocyte deposition and the reduction was greater in the LAD than in the circumflex region. Myocardial platelet and leukocyte deposition was found after regional ischemia, cardioplegia, and cardiopulmonary bypass. Dipyridamole reduced myocardial platelet and leukocyte deposition and may reduce perioperative ischemic injury.

AB - Urgent coronary revascularization for acute myocardial ischemia results in an increased mortality and morbidity. Deposition of activated platelets and leukocytes into the ischemic myocardium during reperfusion may augment perioperative ischemic injury. Dipyridamole reduces platelet activation and may reduce myocardial deposition and prevent ischemic injury during reperfusion. The effects of dipyridamole on myocardial platelet and leukocyte deposition were evaluated in a canine model of acute regional myocardial ischemia with reperfusion during cardioplegia on cardiopulmonary bypass. Eight dogs underwent left anterior descending (LAD) coronary artery ligation for 45 min followed by cardiopulmonary bypass and release of the ligature during 60 min of cold crystalloid cardioplegic arrest to stimulate urgent revascularization. Four dogs were randomized to receive an infusion of dipyridamole perioperatively (50 mg/hr) and 4 dogs served as controls. Autologous platelets were labeled with 111In, leukocytes with 99mTc, and erythrocytes with 51Cr. The labeled cells were infused immediately after cross-clamp release and myocardial biopsies were obtained at 10, 20, 30, and 60 min of reperfusion. Platelets were deposited in the myocardium during reperfusion and four times more platelets were found in the LAD region than the circumflex region. Leukocyte deposition was similar in the LAD and circumflex regions. Dipyridamole reduced both platelet and leukocyte deposition and the reduction was greater in the LAD than in the circumflex region. Myocardial platelet and leukocyte deposition was found after regional ischemia, cardioplegia, and cardiopulmonary bypass. Dipyridamole reduced myocardial platelet and leukocyte deposition and may reduce perioperative ischemic injury.

UR - http://www.scopus.com/inward/record.url?scp=0023239889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023239889&partnerID=8YFLogxK

U2 - 10.1016/0022-4804(87)90008-4

DO - 10.1016/0022-4804(87)90008-4

M3 - Article

C2 - 3586631

AN - SCOPUS:0023239889

VL - 42

SP - 642

EP - 652

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 6

ER -